BIOTRONIK’s Post

management is key, cross-collaboration and alignment on vision is critical to a good deal!

🚀 What pharma wants: The industry's dealmakers look ahead at 2024 🚀 Were you able to attend today's #jpm2024, if not, check out these insights. As we venture into 2024, the pharmaceutical industry is at a pivotal junction, blending scientific discovery with strategic foresight. This year, it's not just about what we're developing, but how we're innovating through collaborations and partnerships. We must dive deep into the science (not finances), prioritizing patient-centric solutions, and aligning our visions to drive transformative outcomes. Let's connect, collaborate, and create a future where healthcare innovation isn't just a goal, but a reality. Remember, most deals start as collaborations. Resiliency is required and you have to play the long game. An incredible presentation and insight into this was presented at JPM Healthcare today by: Glenn Hunzinger Rachna Khosla James Sabry Devang Bhuva John Carroll #InnovateHealthcare #FutureOfHealthcare #innovation #PharmaPartnerships

To successfully conduct a clinical trial, a biotech company needs a robust team of professionals, including physicians, statisticians, and regulatory experts, among others. This also requires an in-depth understanding of various functions, from clinical development pathways to patient enrolment strategies. However, biotech companies, especially new or smaller ones, often lack the comprehensive resources necessary to navigate these complexities. Discover more with HiRO, contact us #hiro #complexity #clinicaltrials #ai #innovation #clinicalscience #medicaladvancements #staffingservices #dataanalysis #costsavings #timemanagement #ceoinsights #greatteam #consulting

🌐 How do you transition from local R&D to global commercial success in BioPharma?   📘 Find out in our newly released whitepaper, packed with expert insights and actionable strategies – a must-read for #biotech firms looking to scale globally.   🔬 The whitepaper includes topics such as: - Integrating commercial thinking into R&D from the start - Pitfalls of emerging innovator companies - Launching a first product while building the organization - Setting realistic expectations for biotech fundraising and launch - 7 “make or break” factors for emerging biopharma companies   💡 Whether you are preparing for your first product launch or looking to refine your approach to global markets, this guide helps you navigate the complexities of the #biopharma industry.   👇 Swipe through the whitepaper below or download the full version here: https://lnkd.in/d7KB9K73.   🔍 If you want to find out more about the vibrant biotech ecosystem in the Greater Zurich Area, please click here: https://lnkd.in/dA6YX8yD.   Nicola Heffron, Alexion Pharmaceuticals, Inc.; Joe Magliocco, Blue Matter; Paul Pospisil, Korn Ferry; Thomas W. Fuchs, MSc, MBA, Economic Promotion Canton of Zug #innovation #pharma #research #development #commercialization

A Monumental Shift in Irish Life Sciences 🌍💼 Chanelle Pharma, Ireland's flagship in generic drug manufacturing, embarks on a new journey with U.K. private equity firm Exponent. In a landmark deal estimated at €300M, this partnership marks a pivotal moment, promising to fuel innovation and growth. With a heritage of excellence and a workforce of over 700, Chanelle Pharma's legacy in human and animal generics is set to soar to new heights. Here's to the future of pharmaceuticals, where tradition meets innovation. 🍀 At Oleson, this development captures our attention for its profound implications on operational excellence and innovation within the life sciences sector. Our commitment to solving business challenges through technical talent resourcing and operational technology consultancy positions us as a pivotal partner in navigating these industry shifts. 🔬 Oleson drives client success,  providing continuity and stability and we are proud to support our clients striding ahead in the face of skill shortages and technological advancements. #LifeSciences #Innovation #Oleson

The pace of innovation in healthcare is accelerating and the shift in patient care models in a post covid world has been profound. Alongside, the opportunity from the emergence of AI is yet to be fully appreciated. There are some very interesting drivers in this sector, If you would like to discuss please reach out, I would be happy to expand on our thematic thinking at Global Investment Services. #privatewealth #healthcare #thematicinvesting #hnw #familyoffices

Good insights by our CIO around one of our key themes - Healthcare and the key drivers of the opportunity in this sector globally. Global Healthcare, one of our primary theme’s and part of our Global Investment Service, exclusively available to our Private bank clients focuses on the opportunities arising from ageing population, increased innovation in biotech and medical devices as well as the evolution of the care model. Feel free to contact me for a private and confidential discussion and to be part of Westpac Private. Your PB!! #westpacprivatebank #globalhealthcare #investments #westpac #privateclients

At Westpac Private Bank, our proactive approach allows us to identify key drivers and exclusive investment opportunities across various themes. Our team of Private Bankers and Investment Directors are eager to share our insights and convictions on global healthcare. If you would like to learn more about Global Investment Services, please reach out to me. #privatebanking #investment #markets

We are excited to officially introduce TYD Partners, your partner in advancing business development within the life sciences industry. We firmly believe that the low percentage of Biotech companies that successfully bring their innovations to market, is not always due to the science itself, but often because of the lack of opportunities to present your breakthroughs to the right pharmaceutical companies or investors.     At TYD Partners, our mission is to empower Biotech's to achieve their full potential. By leveraging our strategic business development plans and extensive network, we aim to significantly improve these success rates.     Our tailored consulting services are designed to meet your unique needs, whether it's working on your positioning, forming valuable partnerships, or driving strategic growth.     Join us on this transformative journey. Follow our page for industry insights, trends, and updates. Contact us to learn more about how TYD Partners can support your business objectives. We look forward to connecting and exploring how we can work together to make your innovations a success.     Here’s to a future where innovation meets opportunity.     #LifeSciences #Biotech #BusinessDevelopment #Innovation #Pharma #TYDPartners